McKesson Competitive Intelligence & Landscape

McKesson (mckesson.com) is a U.S.-based company with a rich history dating back to 1833, establishing itself as a global leader in healthcare solutions. Headquartered in Irving, Texas, McKesson serves as the logistical and operational backbone of the U.S. healthcare system, ensuring patients receive necessary therapies and care. The company's mission revolves around improving patient care by powering healthcare locally and addressing challenges related to access and affordability. Its commitment is highlighted by its values-driven approach to improving care in every setting.

McKesson's core business segments include North American Pharmaceutical, Oncology and Multispecialty, Medical-Surgical Solutions, and Prescription Technology Solutions. Through its North American Pharmaceutical segment, McKesson distributes pharmaceuticals and medical supplies across the United States and Canada, supporting various healthcare settings from pharmacies and hospitals to doctors' offices and clinics. This segment utilizes a digitally connected distribution network and extensive physical infrastructure to deliver medicines and therapies safely, reliably, and on time.

Beyond distribution, McKesson provides a suite of business solutions, bringing together leading technologies, innovative solutions, and hands-on expertise to support the entire healthcare ecosystem. This includes pharmacy services to aid the financial well-being of pharmacies, oncology & multispecialty solutions offering research and insights for cancer and specialty care, and biopharma capabilities that bridge gaps between biopharma companies, pharmacies, providers, and payers to improve medication access and adherence. The company also offers prescription benefit solutions for employers, payers, and government agencies.

McKesson employs approximately 43,000 employees worldwide and operates facilities across the U.S. and Canada, with business hubs in Virginia, Ohio, and Quebec in addition to its Texas headquarters. The company targets a broad market including patients, providers, pharmacies, manufacturers, and health systems across North America, aiming to improve health outcomes for all through its diverse family of brands and innovative solutions.

McKesson offers a range of product and pricing intelligence solutions, primarily through its McKesson Connect online pharmaceutical ordering platform.

McKesson Connect provides users with real-time pricing and inventory levels, order status tracking, advanced search capabilities, robust reporting, and an interactive pharmacy peer community [mckesson.com/pharmacy-technology/pharmaceutical-ordering/drug-ordering/]. This platform also facilitates up-to-date product and pricing information, intuitive ordering and return functionality, inventory management, purchase history reporting, and customer payment solutions [mckesson.com/pharmacy-technology/pharmaceutical-ordering/drug-returns/].

For more in-depth analysis of purchases, prices, and contracts, McKesson Enterprise Reporting and Analytics (ERA) is available. ERA is an online platform that provides access to numerous predefined solutions and custom data sets, enabling customers to create ad-hoc reports with various options and criteria [mckesson.com/pharmacy-technology/solutions-software/pharmacy-management-software/enterprise-reporting-analytics/]. Additionally, McKesson Pharmacy Systems (MPS) Business Services aims to improve profitability and streamline operations for pharmacies, assisting with merchant processing and navigating market changes [mckesson.com/pharmacy-technology/solutions-software/business-solutions/business-services/].

McKesson helps pharmacies manage pharmaceutical costs through competitive generic drug pricing via its proprietary purchasing and distribution programs, OneStop Generics™ and SynerGx® [mckesson.com/pharmaceutical-distribution/pharmaceutical-products/generic-drugs/]. They also offer custom formulary building, providing access to a wide selection of brand name and generic drugs, including exclusive private-label pharmaceuticals, OTC medications, and medical-surgical supplies, to secure cost-efficient products [mckesson.com/pharmaceutical-distribution/pharmaceutical-products/generic-drugs/drug-formulary/].

For specialty and retail group purchasing organizations (GPOs), McKesson leverages collective buying power to enhance operational efficiency and negotiate competitive pricing [mckesson.com/business-solutions/our-businesses/gpo-strategies/]. While specific pricing plans, tiers, or recent pricing changes are not detailed for these intelligence tools, the platforms and services are designed to offer value through improved efficiency and cost management for healthcare providers and pharmacies.

McKesson actively seeks to expand its workforce, with numerous open positions indicating a focus on strengthening its core operations and strategic initiatives. The company's career portal, careers.mckesson.com, highlights a variety of roles, emphasizing its commitment to improving healthcare access, affordability, and reliability through work in distribution, technology, clinical support, and corporate functions. With approximately 43,000 employees globally, McKesson offers opportunities to "make a meaningful impact" in the healthcare system [mckesson.com].

Hiring trends at McKesson show a strong demand across several key areas. For instance, there are 115 jobs listed in Distribution Operations, 56 in Business & Strategy, and 22 in Customer Service & Relations [careers.mckesson.com]. The company also has a significant number of remote positions, with 53 remote jobs available, showcasing flexibility in its hiring approach [careers.mckesson.com/en/location/remote-jobs/733/1000000000100/2]. Geographically, there are opportunities in various U.S. states like Florida and New Jersey, as well as specific cities such as Memphis and Irving, Texas [careers.mckesson.com/en/location/florida-united-states-jobs/733/6252001-4155751/3][careers.mckesson.com/en/location/new-jersey-united-states-jobs/733/6252001-5101760/3][careers.mckesson.com/en/location/memphis-jobs/733/6252001-4662168-4641239/4].

Notable job openings include a Sr. Software Engineer position in Irving, Texas, indicating a continued investment in technology and digital solutions to support its healthcare ecosystem [careers.mckesson.com/en/job/irving/sr-software-engineer/733/96661940288]. The demand for roles in Distribution Operations, such as a Transportation Supervisor in Brampton, Ontario, further underscores McKesson's role as the logistical backbone of the U.S. healthcare system and its reach into Canada [mckesson.com][careers.mckesson.com/en/search_jobs?acm=ALL&alrpm=ALL&ascf=%5B%7B%22key%22%3A%22custom_fields.CareerArea%22%2C%22value%22%3A%22Distribution%22%7D%5D].

While the provided information does not detail any specific layoffs, McKesson's robust hiring patterns across multiple business segments signal a strategic focus on growth and enhancement of its service offerings. The company's continuous recruitment for roles in distribution, strategy, and technology indicates an ongoing commitment to strengthening its operational capabilities and adapting to the evolving demands of the healthcare industry, reinforcing its mission to make healthcare happen [mckesson.com].

McKesson (mckesson.com) has demonstrated robust financial performance, with its investor relations (investor.mckesson.com/overview/default.aspx) providing detailed annual reports (investor.mckesson.com/financials/annual-reports/default.aspx), quarterly results (investor.mckesson.com/financials/quarterly-results/default.aspx), and SEC filings (investor.mckesson.com/financials/sec-filings/default.aspx). For the fiscal year ended March 31, 2025, the company reported consolidated revenues of $359.1 billion, marking a 16% increase, with earnings per diluted share at $25.72 and adjusted earnings per diluted share at $33.05 (www.mckesson.com/about-us/newsroom/press-releases/2025/mckesson-reports-fiscal-2025-fourth-quarter-and-full-year-results/).

The company continued its growth into fiscal year 2026. For the first quarter ending June 30, 2025, McKesson reported consolidated revenues of $97.8 billion, a 23% increase, and adjusted earnings per diluted share of $8.26 (www.mckesson.com/about-us/newsroom/press-releases/2025/mckesson-corporation-reports-fiscal-2026-first-quarter-results/). The second quarter, ending September 30, 2025, saw record high quarterly consolidated revenues of $103.2 billion, up 10%, with adjusted earnings per diluted share increasing by 39% to $9.86 (www.mckesson.com/about-us/newsroom/press-releases/2025/mckesson-corporation-reports-fiscal-2026-second-quarter-results-and-raises-full-year-adjusted-eps-guidance/). Cash flow from operations reached $2.4 billion, and free cash flow was $2.2 billion in this period (www.mckesson.com/about-us/newsroom/press-releases/2025/mckesson-corporation-reports-fiscal-2026-second-quarter-results-and-raises-full-year-adjusted-eps-guidance/).

In the third quarter of fiscal 2026, ending December 31, 2025, McKesson achieved $106.2 billion in consolidated revenues, an 11% increase, and adjusted earnings per diluted share of $9.34, up 16% (www.mckesson.com/about-us/newsroom/press-releases/2026/mckesson-corporation-reports-fiscal-2026-third-quarter-results/). The fourth quarter of fiscal 2026, ending March 31, 2026, reported consolidated revenues of $96.3 billion, a 6% increase, and adjusted earnings per diluted share of $11.69, a 16% increase (www.mckesson.com/about-us/newsroom/press-releases/2026/mckesson-reports-fiscal-2026-fourth-quarter-and-full-year-results/).

Regarding capital allocation, McKesson initiated a $2.25 billion accelerated share repurchase program and its Board of Directors approved a $5.0 billion increase to the share repurchase program (www.mckesson.com/about-us/newsroom/press-releases/2026/mckesson-reports-fiscal-2026-fourth-quarter-and-full-year-results/). The company also completed the acquisition of controlling interests in PRISM Vision Holdings, LLC and Core Ventures during the first quarter of fiscal 2026 (www.mckesson.com/about-us/newsroom/press-releases/2025/mckesson-corporation-reports-fiscal-2026-first-quarter-results/). Additionally, McKesson completed the sale of its Norwegian retail and distribution business in the third quarter of fiscal 2026 (www.mckesson.com/about-us/newsroom/press-releases/2026/mckesson-corporation-reports-fiscal-2026-third-quarter-results/).

McKesson actively participates in and hosts numerous events, including major conferences, to engage with healthcare professionals and advance industry solutions. For instance, McKesson leaders are present at the HealthTrust University Conference, where they connect with health system leaders, clinicians, and supply chain experts to discuss priorities in pharmacy, operations, and strategy [mckesson.com/health-systems/mckesson-health-systems-events/].

The company is a prominent fixture at key oncology events, including the COA Community Oncology Conference 2026 (April 28-29, 2026), where professionals gather to learn about advancements in cancer care and advocate for patient access [mckesson.com/specialty/events/coa-community-oncology-conference/].

McKesson also has a significant presence at the 2026 ASCO Meeting (May 29 - June 2, 2026), featuring over 200 sessions focused on improving cancer outcomes worldwide [mckesson.com/specialty/events/asco/]. Additionally, McKesson participates in the 30th Annual 340B Coalition Summer Conference (July 13–15), addressing challenges and ensuring compliance in 340B programs for health systems [mckesson.com/health-systems/prescribed-perspectives/upcoming-event-340b-coalition-summer-conference/].

McKesson also engages in events centered on broader healthcare topics, such as Becker’s 16th Annual Meeting (April 13–16 in Chicago), where they sponsor a C-suite roundtable focusing on cost efficiency and sustainable growth for health systems [mckesson.com/health-systems/prescribed-perspectives/upcoming-event-beckers-16th-annual-meeting/]. They are also involved in the THMA Pharmacy Growth Collaborative (June 3–5, 2026 in Carlsbad, CA), an exclusive forum for senior health system pharmacy leaders and industry organizations [mckesson.com/health-systems/prescribed-perspectives/thma-pharmacy-growth-collaborative/]. Furthermore, McKesson will lead discussions on the future of specialty pharmacy at AXS26, addressing regulatory shifts and operational agility [mckesson.com/health-systems/prescribed-perspectives/upcoming-event-navigating-the-future-of-specialty-pharmacy-at-axs26/].

Beyond healthcare-specific events, McKesson participates in investor-focused conferences, such as the Barclays Global Healthcare Conference on March 11, 2026 [investor.mckesson.com/events-and-presentations/event-details/2026/Barclays-Global-Healthcare-Conference-2026-c6m3TGqkTC/default.aspx]. The company also hosts its own premier event, McKesson ideaShare 2026, scheduled for June 18-21, 2026, in Denver, CO. This event is designed for independent pharmacy owners and their teams, offering educational, networking, and collaborative opportunities to help independent pharmacies thrive [mckesson.com/about-us/newsroom/press-releases/2026/mckesson-ideashare-2026-invites-independent-pharmacists-to-learn-connect-and-grow/].